Back to Trades
ENANTA PHARMACEUTICALS INC
ENTACIK: 0001177648
Follow ENTA
Track ENANTA PHARMACEUTICALS INC insider trades on your dashboard. Email alerts with a subscription.
ENANTA PHARMACEUTICALS INC (ENTA) has recorded 29 insider filings from 11 unique insiders, totaling $12.5M in trading activity (net selling). Insiders have sold $183.2K while purchasing $0. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is Luly Jay R.. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$12.5M
Purchases
$0
Sales
$183.2K
Unique Insiders
11
Recent Insider Trades
29 loaded
| Mar 13 | ENTA ENANTA PHARMACEUTICALS INC | FOLETTA MARK G | Director | Other | $0 |
| Mar 13 | ENTA ENANTA PHARMACEUTICALS INC | Vance Terry | Director | Other | $0 |
| Mar 13 | ENTA ENANTA PHARMACEUTICALS INC | Hata Yujiro S | Director | Other | $0 |
| Feb 13 | ENTA ENANTA PHARMACEUTICALS INC | Kowalsky Matthew Paul | Chief Legal Officer | Grant | $0 |
| Feb 13 | ENTA ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Grant | $0 |
| Feb 13 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Grant | $0 |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Or Yat Sun | Chief Scientific Officer | Sell | $34.0K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Luly Jay R. | President and CEO, Director | Sell | $67.5K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Sell | $11.4K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Trout Harry R. III | See Remarks | Sell | $7.7K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | Sell | $4.6K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Sell | $30.0K |
| Dec 5 | ENTA ENANTA PHARMACEUTICALS INC | Luu Brendan | Chief Business Officer | Sell | $19.8K |
| Dec 3 | ENTA ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | Sell | $2.9K |
| Dec 3 | ENTA ENANTA PHARMACEUTICALS INC | Luly Jay R. | President and CEO, Director | Other | $0 |
| Dec 3 | ENTA ENANTA PHARMACEUTICALS INC | Luu Brendan | Chief Business Officer | Other | $0 |
| Dec 3 | ENTA ENANTA PHARMACEUTICALS INC | Trout Harry R. III | See Remarks | Sell | $5.3K |
| Dec 3 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Other | $0 |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Trout Harry R. III | See Remarks | Grant | $0 |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Luu Brendan | Chief Business Officer | Other | $0 |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Or Yat Sun | Chief Scientific Officer | Other | $0 |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Kowalsky Matthew Paul | Chief Legal Officer | Other | $0 |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Kieffer Tara Lynn | Chief Product Strategy Officer | Other | $0 |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Other | $0 |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | Grant | $0 |
| Nov 26 | ENTA ENANTA PHARMACEUTICALS INC | Luly Jay R. | President and CEO, Director | Other | $0 |
| Sep 8 | ENTA ENANTA PHARMACEUTICALS INC | Trout Harry R. III | Vice President, Finance | Other | $0 |
| Sep 8 | ENTA ENANTA PHARMACEUTICALS INC | Capps Kathleen S. | See Remarks | Other | $0 |
| Aug 8 | ENTA ENANTA PHARMACEUTICALS INC | Rottinghaus Scott T. | Chief Medical Officer | Other | $0 |
29 filings